nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.065	0.282	CbGbCtD
Indapamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0439	0.19	CbGbCtD
Indapamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0419	0.182	CbGbCtD
Indapamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0373	0.162	CbGbCtD
Indapamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0219	0.095	CbGbCtD
Indapamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0207	0.0897	CbGbCtD
Indapamide—KCNE1—respiratory system—chronic obstructive pulmonary disease	0.0183	0.143	CbGeAlD
Indapamide—KCNE1—bronchus—chronic obstructive pulmonary disease	0.0151	0.117	CbGeAlD
Indapamide—KCNE1—lung—chronic obstructive pulmonary disease	0.00972	0.0757	CbGeAlD
Indapamide—SLC12A3—respiratory system—chronic obstructive pulmonary disease	0.00904	0.0704	CbGeAlD
Indapamide—KCNQ1—respiratory system—chronic obstructive pulmonary disease	0.0084	0.0655	CbGeAlD
Indapamide—KCNQ1—bronchus—chronic obstructive pulmonary disease	0.00692	0.0539	CbGeAlD
Indapamide—CA7—trachea—chronic obstructive pulmonary disease	0.00682	0.0531	CbGeAlD
Indapamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00599	0.0467	CbGeAlD
Indapamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00528	0.0411	CbGeAlD
Indapamide—SLC12A3—lung—chronic obstructive pulmonary disease	0.0048	0.0374	CbGeAlD
Indapamide—KCNQ1—lung—chronic obstructive pulmonary disease	0.00446	0.0348	CbGeAlD
Indapamide—CA12—trachea—chronic obstructive pulmonary disease	0.00443	0.0345	CbGeAlD
Indapamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00371	0.0289	CbGeAlD
Indapamide—CA12—lung—chronic obstructive pulmonary disease	0.00318	0.0248	CbGeAlD
Indapamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00308	0.024	CbGeAlD
Indapamide—CA5B—lung—chronic obstructive pulmonary disease	0.00286	0.0222	CbGeAlD
Indapamide—CA4—trachea—chronic obstructive pulmonary disease	0.00274	0.0214	CbGeAlD
Indapamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00271	0.0211	CbGeAlD
Indapamide—CA2—bronchus—chronic obstructive pulmonary disease	0.00253	0.0197	CbGeAlD
Indapamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00248	0.0193	CbGeAlD
Indapamide—CA2—trachea—chronic obstructive pulmonary disease	0.00227	0.0177	CbGeAlD
Indapamide—CA4—lung—chronic obstructive pulmonary disease	0.00197	0.0154	CbGeAlD
Indapamide—CA2—lung—chronic obstructive pulmonary disease	0.00163	0.0127	CbGeAlD
Indapamide—Furosemide—ALB—chronic obstructive pulmonary disease	0.00138	0.624	CrCbGaD
Indapamide—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000832	0.376	CrCbGaD
Indapamide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000706	0.056	CbGpPWpGaD
Indapamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000641	0.00102	CcSEcCtD
Indapamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00102	CcSEcCtD
Indapamide—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000637	0.00102	CcSEcCtD
Indapamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00101	CcSEcCtD
Indapamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00101	CcSEcCtD
Indapamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00101	CcSEcCtD
Indapamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00101	CcSEcCtD
Indapamide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00101	CcSEcCtD
Indapamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.001	CcSEcCtD
Indapamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000628	0.001	CcSEcCtD
Indapamide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000624	0.0495	CbGpPWpGaD
Indapamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.000995	CcSEcCtD
Indapamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.000995	CcSEcCtD
Indapamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.000995	CcSEcCtD
Indapamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.000994	CcSEcCtD
Indapamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.000992	CcSEcCtD
Indapamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.000991	CcSEcCtD
Indapamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00062	0.000991	CcSEcCtD
Indapamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.000989	CcSEcCtD
Indapamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000619	0.000989	CcSEcCtD
Indapamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000619	0.000989	CcSEcCtD
Indapamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000617	0.000986	CcSEcCtD
Indapamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.000986	CcSEcCtD
Indapamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000615	0.000983	CcSEcCtD
Indapamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000615	0.000983	CcSEcCtD
Indapamide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.000982	CcSEcCtD
Indapamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.000981	CcSEcCtD
Indapamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000614	0.000981	CcSEcCtD
Indapamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000612	0.000978	CcSEcCtD
Indapamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.000973	CcSEcCtD
Indapamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00097	CcSEcCtD
Indapamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000607	0.000969	CcSEcCtD
Indapamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000602	0.000961	CcSEcCtD
Indapamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.000954	CcSEcCtD
Indapamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.000954	CcSEcCtD
Indapamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.000948	CcSEcCtD
Indapamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.000944	CcSEcCtD
Indapamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000591	0.000944	CcSEcCtD
Indapamide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000591	0.000943	CcSEcCtD
Indapamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000588	0.000939	CcSEcCtD
Indapamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.000938	CcSEcCtD
Indapamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.000935	CcSEcCtD
Indapamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.000931	CcSEcCtD
Indapamide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000582	0.00093	CcSEcCtD
Indapamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.000926	CcSEcCtD
Indapamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000577	0.000922	CcSEcCtD
Indapamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.000922	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00092	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00092	CcSEcCtD
Indapamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000572	0.000914	CcSEcCtD
Indapamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.000914	CcSEcCtD
Indapamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.000909	CcSEcCtD
Indapamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000569	0.000908	CcSEcCtD
Indapamide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000566	0.000904	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000564	0.000901	CcSEcCtD
Indapamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000564	0.000901	CcSEcCtD
Indapamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.000901	CcSEcCtD
Indapamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.000898	CcSEcCtD
Indapamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000562	0.000898	CcSEcCtD
Indapamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00056	0.000895	CcSEcCtD
Indapamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.000891	CcSEcCtD
Indapamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.000889	CcSEcCtD
Indapamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000557	0.000889	CcSEcCtD
Indapamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000556	0.000888	CcSEcCtD
Indapamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000554	0.000886	CcSEcCtD
Indapamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000551	0.00088	CcSEcCtD
Indapamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000549	0.000878	CcSEcCtD
Indapamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000546	0.000872	CcSEcCtD
Indapamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000546	0.000872	CcSEcCtD
Indapamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000545	0.000871	CcSEcCtD
Indapamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.000871	CcSEcCtD
Indapamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000545	0.000871	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.000869	CcSEcCtD
Indapamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.000864	CcSEcCtD
Indapamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000541	0.000864	CcSEcCtD
Indapamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000541	0.000864	CcSEcCtD
Indapamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.000864	CcSEcCtD
Indapamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.000863	CcSEcCtD
Indapamide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000539	0.000861	CcSEcCtD
Indapamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000539	0.000861	CcSEcCtD
Indapamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.000856	CcSEcCtD
Indapamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000535	0.000854	CcSEcCtD
Indapamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000534	0.000853	CcSEcCtD
Indapamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.00085	CcSEcCtD
Indapamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.000848	CcSEcCtD
Indapamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00053	0.000846	CcSEcCtD
Indapamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.000844	CcSEcCtD
Indapamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00084	CcSEcCtD
Indapamide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000839	CcSEcCtD
Indapamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000524	0.000837	CcSEcCtD
Indapamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.000836	CcSEcCtD
Indapamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000522	0.000834	CcSEcCtD
Indapamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.000832	CcSEcCtD
Indapamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000521	0.000832	CcSEcCtD
Indapamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000521	0.000831	CcSEcCtD
Indapamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.000829	CcSEcCtD
Indapamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.000828	CcSEcCtD
Indapamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000517	0.000826	CcSEcCtD
Indapamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.000826	CcSEcCtD
Indapamide—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000825	CcSEcCtD
Indapamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.000823	CcSEcCtD
Indapamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.000822	CcSEcCtD
Indapamide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000511	0.0405	CbGpPWpGaD
Indapamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.000816	CcSEcCtD
Indapamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.000816	CcSEcCtD
Indapamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000507	0.000809	CcSEcCtD
Indapamide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000809	CcSEcCtD
Indapamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000502	0.000802	CcSEcCtD
Indapamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.000802	CcSEcCtD
Indapamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.000799	CcSEcCtD
Indapamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0005	0.000799	CcSEcCtD
Indapamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.000799	CcSEcCtD
Indapamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0005	0.000799	CcSEcCtD
Indapamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.000796	CcSEcCtD
Indapamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.000789	CcSEcCtD
Indapamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.000788	CcSEcCtD
Indapamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000494	0.000788	CcSEcCtD
Indapamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000492	0.000786	CcSEcCtD
Indapamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.000786	CcSEcCtD
Indapamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.000784	CcSEcCtD
Indapamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00049	0.000782	CcSEcCtD
Indapamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00049	0.000782	CcSEcCtD
Indapamide—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000489	0.000781	CcSEcCtD
Indapamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00078	CcSEcCtD
Indapamide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000772	CcSEcCtD
Indapamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.000758	CcSEcCtD
Indapamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.000754	CcSEcCtD
Indapamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.000754	CcSEcCtD
Indapamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000466	0.000744	CcSEcCtD
Indapamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.000744	CcSEcCtD
Indapamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.000743	CcSEcCtD
Indapamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000465	0.000742	CcSEcCtD
Indapamide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000736	CcSEcCtD
Indapamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000456	0.000729	CcSEcCtD
Indapamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000454	0.000725	CcSEcCtD
Indapamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.000725	CcSEcCtD
Indapamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000447	0.000715	CcSEcCtD
Indapamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.000715	CcSEcCtD
Indapamide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000447	0.000713	CcSEcCtD
Indapamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00071	CcSEcCtD
Indapamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.000703	CcSEcCtD
Indapamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000438	0.0007	CcSEcCtD
Indapamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000433	0.000691	CcSEcCtD
Indapamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.000691	CcSEcCtD
Indapamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000431	0.000688	CcSEcCtD
Indapamide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000429	0.000685	CcSEcCtD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—chronic obstructive pulmonary disease	0.000429	0.034	CbGpPWpGaD
Indapamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.000684	CcSEcCtD
Indapamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000424	0.000677	CcSEcCtD
Indapamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.000675	CcSEcCtD
Indapamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.00067	CcSEcCtD
Indapamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.000668	CcSEcCtD
Indapamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000418	0.000668	CcSEcCtD
Indapamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00041	0.000654	CcSEcCtD
Indapamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.000653	CcSEcCtD
Indapamide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000644	CcSEcCtD
Indapamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000402	0.000642	CcSEcCtD
Indapamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.000642	CcSEcCtD
Indapamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.000637	CcSEcCtD
Indapamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000399	0.000637	CcSEcCtD
Indapamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.000636	CcSEcCtD
Indapamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000398	0.000636	CcSEcCtD
Indapamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.000633	CcSEcCtD
Indapamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000396	0.000633	CcSEcCtD
Indapamide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000632	CcSEcCtD
Indapamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.000632	CcSEcCtD
Indapamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000631	CcSEcCtD
Indapamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.000631	CcSEcCtD
Indapamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000394	0.000629	CcSEcCtD
Indapamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000391	0.000624	CcSEcCtD
Indapamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00039	0.000623	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.000622	CcSEcCtD
Indapamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000622	CcSEcCtD
Indapamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00062	CcSEcCtD
Indapamide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.000612	CcSEcCtD
Indapamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.000606	CcSEcCtD
Indapamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.000604	CcSEcCtD
Indapamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000602	CcSEcCtD
Indapamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.000601	CcSEcCtD
Indapamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.000601	CcSEcCtD
Indapamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.000601	CcSEcCtD
Indapamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000376	0.0006	CcSEcCtD
Indapamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.0006	CcSEcCtD
Indapamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.000598	CcSEcCtD
Indapamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000369	0.000589	CcSEcCtD
Indapamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000368	0.000588	CcSEcCtD
Indapamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.000567	CcSEcCtD
Indapamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000353	0.000564	CcSEcCtD
Indapamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.000547	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.000547	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000341	0.0271	CbGpPWpGaD
Indapamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.000538	CcSEcCtD
Indapamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.000534	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.000529	CcSEcCtD
Indapamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000519	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000319	0.0253	CbGpPWpGaD
Indapamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000313	0.0005	CcSEcCtD
Indapamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000495	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000308	0.0244	CbGpPWpGaD
Indapamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.000491	CcSEcCtD
Indapamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000305	0.000487	CcSEcCtD
Indapamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000305	0.000487	CcSEcCtD
Indapamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.000468	CcSEcCtD
Indapamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000459	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000452	CcSEcCtD
Indapamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.000451	CcSEcCtD
Indapamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00045	CcSEcCtD
Indapamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000448	CcSEcCtD
Indapamide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000445	CcSEcCtD
Indapamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000439	CcSEcCtD
Indapamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000438	CcSEcCtD
Indapamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000437	CcSEcCtD
Indapamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.000435	CcSEcCtD
Indapamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000428	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000261	0.0207	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00026	0.0206	CbGpPWpGaD
Indapamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000415	CcSEcCtD
Indapamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000415	CcSEcCtD
Indapamide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.0206	CbGpPWpGaD
Indapamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000413	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000412	CcSEcCtD
Indapamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00041	CcSEcCtD
Indapamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000403	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000398	CcSEcCtD
Indapamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000398	CcSEcCtD
Indapamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000395	CcSEcCtD
Indapamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000391	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00039	CcSEcCtD
Indapamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000388	CcSEcCtD
Indapamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000386	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000384	CcSEcCtD
Indapamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000379	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000233	0.0185	CbGpPWpGaD
Indapamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000362	CcSEcCtD
Indapamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.000362	CcSEcCtD
Indapamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00036	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000357	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00035	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000346	CcSEcCtD
Indapamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000345	CcSEcCtD
Indapamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000345	CcSEcCtD
Indapamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000343	CcSEcCtD
Indapamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000343	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000213	0.0169	CbGpPWpGaD
Indapamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00034	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00021	0.0167	CbGpPWpGaD
Indapamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000328	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000325	CcSEcCtD
Indapamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000325	CcSEcCtD
Indapamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000199	0.0158	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000198	0.0157	CbGpPWpGaD
Indapamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000316	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000314	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000314	CcSEcCtD
Indapamide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.000189	0.015	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000189	0.015	CbGpPWpGaD
Indapamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000293	CcSEcCtD
Indapamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000285	CcSEcCtD
Indapamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000281	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000272	CcSEcCtD
Indapamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000263	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000161	0.0128	CbGpPWpGaD
Indapamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000253	CcSEcCtD
Indapamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000251	CcSEcCtD
Indapamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00025	CcSEcCtD
Indapamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000249	CcSEcCtD
Indapamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.0122	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000154	0.0122	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00015	0.0119	CbGpPWpGaD
Indapamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000236	CcSEcCtD
Indapamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.0106	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000127	0.01	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000125	0.0099	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00966	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000117	0.00926	CbGpPWpGaD
Indapamide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00925	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000116	0.00924	CbGpPWpGaD
Indapamide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000116	0.00924	CbGpPWpGaD
Indapamide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00888	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000112	0.00888	CbGpPWpGaD
Indapamide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.000108	0.00856	CbGpPWpGaD
Indapamide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00854	CbGpPWpGaD
Indapamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	9.72e-05	0.00772	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.48e-05	0.00752	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	9.34e-05	0.00741	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.85e-05	0.00702	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.71e-05	0.00691	CbGpPWpGaD
Indapamide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	8.6e-05	0.00682	CbGpPWpGaD
Indapamide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.26e-05	0.00655	CbGpPWpGaD
Indapamide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	8.25e-05	0.00654	CbGpPWpGaD
Indapamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	8.13e-05	0.00645	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.12e-05	0.00644	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	8.04e-05	0.00638	CbGpPWpGaD
Indapamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.82e-05	0.00621	CbGpPWpGaD
Indapamide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.71e-05	0.00612	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.71e-05	0.00612	CbGpPWpGaD
Indapamide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	7.5e-05	0.00595	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	7.5e-05	0.00595	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.47e-05	0.00593	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	7.32e-05	0.00581	CbGpPWpGaD
Indapamide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.15e-05	0.00567	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	7.04e-05	0.00559	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.98e-05	0.00553	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.98e-05	0.00553	CbGpPWpGaD
Indapamide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	6.95e-05	0.00551	CbGpPWpGaD
Indapamide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	6.95e-05	0.00551	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.55e-05	0.0052	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.46e-05	0.00513	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.05e-05	0.0048	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5.75e-05	0.00456	CbGpPWpGaD
Indapamide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.7e-05	0.00452	CbGpPWpGaD
Indapamide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	5.54e-05	0.0044	CbGpPWpGaD
Indapamide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.46e-05	0.00433	CbGpPWpGaD
Indapamide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	5.31e-05	0.00422	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.15e-05	0.00409	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.12e-05	0.00406	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.94e-05	0.00392	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.75e-05	0.00377	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.65e-05	0.00369	CbGpPWpGaD
Indapamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.6e-05	0.00365	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.59e-05	0.00364	CbGpPWpGaD
Indapamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	4.48e-05	0.00355	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.39e-05	0.00348	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	4.34e-05	0.00344	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.18e-05	0.00331	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.16e-05	0.0033	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.1e-05	0.00325	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.1e-05	0.00325	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	4.05e-05	0.00321	CbGpPWpGaD
Indapamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.05e-05	0.00321	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	3.96e-05	0.00314	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.8e-05	0.00301	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.77e-05	0.00299	CbGpPWpGaD
Indapamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	3.75e-05	0.00298	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	3.7e-05	0.00293	CbGpPWpGaD
Indapamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.7e-05	0.00293	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.65e-05	0.0029	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	3.54e-05	0.00281	CbGpPWpGaD
Indapamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	3.43e-05	0.00272	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.0027	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.0027	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.00268	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.33e-05	0.00264	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.16e-05	0.0025	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.08e-05	0.00244	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.04e-05	0.00241	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.03e-05	0.0024	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	3e-05	0.00238	CbGpPWpGaD
Indapamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.99e-05	0.00237	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.9e-05	0.0023	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	2.87e-05	0.00228	CbGpPWpGaD
Indapamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.87e-05	0.00228	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.84e-05	0.00225	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.84e-05	0.00225	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.8e-05	0.00222	CbGpPWpGaD
Indapamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.8e-05	0.00222	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.8e-05	0.00222	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.74e-05	0.00217	CbGpPWpGaD
Indapamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.00217	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.0021	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.63e-05	0.00209	CbGpPWpGaD
Indapamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.62e-05	0.00208	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.61e-05	0.00207	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.61e-05	0.00207	CbGpPWpGaD
Indapamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.6e-05	0.00206	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.002	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.00196	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.00196	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.45e-05	0.00194	CbGpPWpGaD
Indapamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.42e-05	0.00192	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.42e-05	0.00192	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.41e-05	0.00191	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.41e-05	0.00191	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.38e-05	0.00189	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.00182	CbGpPWpGaD
Indapamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.21e-05	0.00175	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.17e-05	0.00172	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.00167	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.00164	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.03e-05	0.00161	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.01e-05	0.0016	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.00159	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.99e-05	0.00158	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.98e-05	0.00157	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.00157	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.00153	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.85e-05	0.00147	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.00145	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	1.8e-05	0.00143	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.75e-05	0.00139	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.00137	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.7e-05	0.00135	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	1.68e-05	0.00133	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	1.68e-05	0.00133	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.67e-05	0.00133	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.00132	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.00131	CbGpPWpGaD
Indapamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.61e-05	0.00128	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	1.61e-05	0.00128	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.00124	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	1.56e-05	0.00124	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.00122	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.0012	CbGpPWpGaD
Indapamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	1.49e-05	0.00118	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.00117	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.00115	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.00114	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000986	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000945	CbGpPWpGaD
Indapamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000943	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.17e-05	0.000928	CbGpPWpGaD
Indapamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000904	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	1e-05	0.000797	CbGpPWpGaD
Indapamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	9.61e-06	0.000762	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.75e-06	0.000615	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.54e-06	0.000598	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.01e-06	0.000556	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.12e-06	0.000327	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.07e-06	0.000323	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.72e-06	0.000295	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.42e-06	0.000272	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.86e-06	0.000227	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.82e-06	0.000223	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.62e-06	0.000208	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.49e-06	0.000197	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.69e-06	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.62e-06	0.000128	CbGpPWpGaD
